BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang T, Huang T, Zhang D, Wang M, Wu B, Shang Y, Sattar S, Ding L, Liu Y, Jiang H, Liang Y, Zhou F, Wei Y. TGF-β receptor inhibitor LY2109761 enhances the radiosensitivity of gastric cancer by inactivating the TGF-β/SMAD4 signaling pathway. Aging (Albany NY) 2019;11:8892-910. [PMID: 31631064 DOI: 10.18632/aging.102329] [Cited by in Crossref: 4] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Chan MK, Chung JY, Tang PC, Chan AS, Ho JY, Lin TP, Chen J, Leung K, To K, Lan H, Tang PM. TGF-β signaling networks in the tumor microenvironment. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.215925] [Reference Citation Analysis]
2 Xu Z, Zhang Y, Dai H, Han B. Epithelial-Mesenchymal Transition-Mediated Tumor Therapeutic Resistance. Molecules 2022;27:4750. [PMID: 35897925 DOI: 10.3390/molecules27154750] [Reference Citation Analysis]
3 Zhu Y, Fan W, Wang Y, Ding H, Yang S, He F, Wang F. Flavokawain B Weakens Gastric Cancer Progression via the TGF-β1/SMAD4 Pathway and Attenuates M2 Macrophage Polarization. Journal of Immunology Research 2022;2022:1-22. [DOI: 10.1155/2022/4903333] [Reference Citation Analysis]
4 Oishi T, Koizumi S, Kurozumi K. Molecular Mechanisms and Clinical Challenges of Glioma Invasion. Brain Sci 2022;12:291. [PMID: 35204054 DOI: 10.3390/brainsci12020291] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Gong Y, Jiao Y, Qi X, Fu J, Qian J, Zhu J, Yang H, Tang L. Construction of a circRNA-miRNA-mRNA network based on differentially co-expressed circular RNA in gastric cancer tissue and plasma by bioinformatics analysis. World J Surg Onc 2022;20. [DOI: 10.1186/s12957-022-02503-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Su H, Ren W, Zhang D. Research progress on exosomal proteins as diagnostic markers of gastric cancer (review article). Clin Exp Med. [DOI: 10.1007/s10238-022-00793-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lai D, Tan L, Zuo X, Liu D, Jiao D, Wan G, Lu C, Shen D, Gu X. Prognostic Ferroptosis-Related lncRNA Signatures Associated With Immunotherapy and Chemotherapy Responses in Patients With Stomach Cancer. Front Genet 2021;12:798612. [PMID: 35047016 DOI: 10.3389/fgene.2021.798612] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
8 Qin H, Li X, Zhang W, Ding Z. LncRNA OGFRP1 promotes cell proliferation and suppresses cell radiosensitivity in gastric cancer by targeting the miR-149-5p/MAP3K3 axis. J Mol Histol. [DOI: 10.1007/s10735-022-10058-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Jank BJ, Lenz T, Haas M, Kadletz-Wanke L, Campion NJ, Schnoell J, Heiduschka G, Macfelda K. Radiosensitizing effect of galunisertib, a TGF-ß receptor I inhibitor, on head and neck squamous cell carcinoma in vitro. Invest New Drugs 2022. [PMID: 34985593 DOI: 10.1007/s10637-021-01207-1] [Reference Citation Analysis]
10 Carlos-Reyes A, Muñiz-Lino MA, Romero-Garcia S, López-Camarillo C, Hernández-de la Cruz ON. Biological Adaptations of Tumor Cells to Radiation Therapy. Front Oncol 2021;11:718636. [PMID: 34900673 DOI: 10.3389/fonc.2021.718636] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Liu X, Zhang Y, Wang Z, Liu L, Zhang G, Li J, Ren Z, Dong Z, Yu Z. PRRC2A Promotes Hepatocellular Carcinoma Progression and Associates with Immune Infiltration. J Hepatocell Carcinoma 2021;8:1495-511. [PMID: 34881207 DOI: 10.2147/JHC.S337111] [Reference Citation Analysis]
12 Chen G, Han Y, Zhang H, Tu W, Zhang S. Radiotherapy-Induced Digestive Injury: Diagnosis, Treatment and Mechanisms. Front Oncol 2021;11:757973. [PMID: 34804953 DOI: 10.3389/fonc.2021.757973] [Reference Citation Analysis]
13 Wang J, Xu Z, Wang Z, Du G, Lun L. TGF-beta signaling in cancer radiotherapy. Cytokine 2021;148:155709. [PMID: 34597918 DOI: 10.1016/j.cyto.2021.155709] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
14 Wang J, Han Q, Liu H, Luo H, Li L, Liu A, Jiang Y. Identification of Radiotherapy-Associated Genes in Lung Adenocarcinoma by an Integrated Bioinformatics Analysis Approach. Front Mol Biosci 2021;8:624575. [PMID: 34212001 DOI: 10.3389/fmolb.2021.624575] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
15 Qin S, Yu Y, Guan H, Yang Y, Sun F, Sun Y, Zhu J, Xing L, Yu J, Sun X. A preclinical study: correlation between PD-L1 PET imaging and the prediction of therapy efficacy of MC38 tumor with 68Ga-labeled PD-L1 targeted nanobody. Aging (Albany NY) 2021;13:13006-22. [PMID: 33910164 DOI: 10.18632/aging.202981] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
16 Kong L, Yu Y, Guan H, Jiang L, Sun F, Li X, Huang W, Li B. TGIF1 plays a carcinogenic role in esophageal squamous cell carcinoma through the Wnt/β‑catenin and Akt/mTOR signaling pathways. Int J Mol Med 2021;47:77. [PMID: 33693954 DOI: 10.3892/ijmm.2021.4910] [Reference Citation Analysis]
17 Zhang BH, Wang C, Dong W, Chen X, Leng C, Luo X, Dong SL, Yin P, Zhang BX, Datta PK, Chen XP. A novel approach for monitoring TGF-β signaling in vivo in colon cancer. Carcinogenesis 2021;42:631-9. [PMID: 33367515 DOI: 10.1093/carcin/bgaa142] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Ma K, Zhang C, Li W. TGF-β is associated with poor prognosis and promotes osteosarcoma progression via PI3K/Akt pathway activation. Cell Cycle 2020;19:2327-39. [PMID: 32804027 DOI: 10.1080/15384101.2020.1805552] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]